Energy and Commerce Unveils Legislation to Reauthorize FDA User Fees, Revamp Accelerated Approvals
- May 06, 2022
Energy and Commerce Committee leaders unveiled this week a much-anticipated legislative package to reauthorize Food and Drug Administration (FDA) user fees, which are set to expire September 30.
ARTICLE TAGS
You must be logged in to access this content.